New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
10:07 EDTTRXC, QTNT, FRSH, GPT, AWH, SLF, SABR, OILT, BKW, AEGR, SRC, PFE, MFC, ARESOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Aegerion (AEGR) initiated with a Sell at Goldman... Allied World (AWH) initiated with a Buy at CRT Capital... Ares Management (ARES) initiated with a Buy at BofA/Merrill... Burger King (BKW) initiated with an Equal Weight at Morgan Stanley... Gramercy Property Trust (GPT) initiated with a Buy at BofA/Merrill... Manulife Financial (MFC) initiated with a Buy at Canaccord... Oiltanking Partners (OILT) initiated with a Market Perform at Wells Fargo... Papa Murphy's (FRSH) initiated with a Buy at Jefferies... Pfizer (PFE) reinstated with a Buy at Goldman... Quotient (QTNT) initiated with a Buy at UBS... Sabre (SABR) initiated with a Buy at BofA/Merrill... Spirit Realty (SRC) initiated with a Neutral at BofA/Merrill... Sun Life Financial (SLF) initiated with a Buy at Canaccord... TransEnterix (TRXC) initiated with an Outperform at RBC Capital.
News For AEGR;AWH;ARES;BKW;GPT;MFC;OILT;FRSH;PFE;SABR;QTNT;SRC;SLF;TRXC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 26, 2015
08:42 EDTMFCJohn Hancock acquires software provider Guide Financial
Subscribe for More Information
08:20 EDTSLF, MFCMorgan Stanley to hold a field trip
Subscribe for More Information
07:11 EDTAEGRAegerion achieves primary endpoint of lomitapide study in Japan
Subscribe for More Information
May 22, 2015
10:52 EDTPFEJPMorgan says Actavis shares cheap compared to peers
Subscribe for More Information
May 21, 2015
11:40 EDTAEGRSarissa Capital raises stake in Aegerion to 7.07% from 5.76%
Subscribe for More Information
07:37 EDTPFEPfizer replaces AbbVie as top global pharma pick at Jefferies
Subscribe for More Information
06:55 EDTSABRSabre 24M share Secondary priced at $26.00
Subscribe for More Information
May 20, 2015
07:46 EDTPFEDeutsche Bank positive on potential Pfizer, GSK merger
Deutsche Bank analyst Gregg Gilbert believes a large foreign deal for Pfizer (PFE) may make sense and says a buyout of GlaxoSmithKline (GSK) could be "materially" accretive to earnings while improving the company's tax situation over time. Gilbert assumes a $60 per share buyout price for GlaxoSmithKline in a research note this morning titled "Introducing 'PfizerKline'". The stock closed yesterday up 2c to $44.68. Gilbert reiterates a Buy rating on Pfizer with a $41 price target. Shares ended yesterday up 23c to $34.21.
07:21 EDTQTNTUBS to hold a conference
Subscribe for More Information
May 19, 2015
06:55 EDTPFEGenocea could be takeover target after data, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff expects Genocea Biosciences (GNCA) will report positive Phase II GEN-003 post-immunization results late in Q2. GEN-003 is a therapeutic vaccine for genital herpes targeting Herpes Simplex Virus Type 2. Positive GEN-003 data could position Genocea as a potential acquisition target by a larger vaccine player, Tenthoff tells investors today in a research note. Large vaccine makers include Sanofi (SNY), Merck (MRK), GlaxoSmithKline (GSK), Pfizer (PFE) and Novartis (NVS). The analyst reiterates an Overweight rating on Genocea with a $14 price target. Shares of the clinical-stage vaccine developer with a $227M market capitalization closed yesterday up 83c to $10.22.
May 18, 2015
16:18 EDTSABRSabre files to sell 22M shares for affiliates of TPG Global and Silver Lake
Goldman, Sachs & Co., BofA Merrill Lynch, Morgan Stanley, Deutsche Bank and Evercore ISI are acting as joint bookrunners for this offering. In addition TPG Capital BD, LLC, Jefferies, Foros, Cowen and Company, Sanford C. Bernstein, William Blair, Mizuho Securities, Natixis and The Williams Capital Group, L.P. are acting as co-managers for this offering.
16:09 EDTSABRSabre files automatic common stock offering
Subscribe for More Information
06:58 EDTPFEActavis CEO says chances of Pfizer offer are 'unlikely', Financial Times says
Actavis (ACT) CEO Brent Saunders said the chances of Pfizer (PFE) making an offer are "incredibly unlikely," reports the Financial Times. Saunders said he has heard the gossip that Actavis could become a takeover target for a larger group, but he spends "zero time thinking about it." Reference Link
May 15, 2015
09:31 EDTPFEAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.
May 14, 2015
17:03 EDTAEGRAegerion CFO resigns, David Aubuchon named acting CFO
Subscribe for More Information
12:29 EDTPFEPfizer receives 'second request' from FTC regarding potential Hospira merger
Subscribe for More Information
08:39 EDTPFETargacept, Catalyst Biosciences amend definitive merger agreement
Subscribe for More Information
08:08 EDTPFEPfizer director Marc Tessier-Lavigne to step down from board
Subscribe for More Information
06:25 EDTSLF, MFCStandard Chartered seeks buyers for Hong Kong pension unit, Reuters reports
Subscribe for More Information
05:45 EDTSABRSabre to acqiure Abacus International for $411M
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use